» Articles » PMID: 17200123

NAD(P)H Oxidases Regulate HIF-2alpha Protein Expression

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2007 Jan 4
PMID 17200123
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Biallelic inactivation of the von Hippel-Lindau tumor suppressor gene (VHL) is linked to the development of hereditary and sporadic renal cell carcinoma (RCC). In the absence of VHL, the alpha subunits of heterodimeric hypoxia-inducible transcription factors (HIF-1alpha and HIF-2alpha) are stabilized. Reactive oxygen species, generated by NAD(P)H oxidases, are involved in signaling cascades of malignant growth. We show that in VHL-deficient cells p22phox, Nox4 protein levels and NADPH-dependent superoxide generation are increased. Reintroduction of VHL into the VHL-deficient cells down-regulates the expression of p22phox and NADPH-dependent superoxide generation. Inhibition of the 26 S proteasome in VHL-expressing cells increased p22phox protein levels, which correlated with an increase of NADPH-dependent superoxide generation. We also show that p22phox co-immunoprecipitates with VHL in vivo. Moreover, p22phox is a target of ubiquitination. Importantly, in VHL-deficient cells, diphenyleneiodonium chloride (DPI), an inhibitor of Nox oxidases, decreased the expression of HIF-2alpha. Down-regulation of Nox1, Nox4, and p22phox expression by small interfering RNA also decreased HIF-2alpha protein expression and inhibited Akt and 4E-BP1 phosphorylation, suggesting that a translational mechanism is involved in maintaining HIF-2alpha in VHL-deficient cells. Colony formation by RCC 786-O in soft agar was markedly inhibited by DPI. Moreover, DPI significantly inhibited RCC 786-O tumor formation in athymic mice. Collectively, the data demonstrate that VHL protein exerts its tumor suppressor action, at least partially, via inhibition of p22phox-based Nox4/Nox1 NADPH oxidase-dependent reactive oxygen species generation.

Citing Articles

as a Potential Biomarker for Renal Cell Carcinoma: Evidence from an Integrated Genetic Analysis.

Chang C, Huang S, Hsueh Y, Chen P, Lee C, Geng J Cancer Genomics Proteomics. 2023; 20(5):469-475.

PMID: 37643785 PMC: 10464943. DOI: 10.21873/cgp.20398.


Endotyping COPD: hypoxia-inducible factor-2 as a molecular "switch" between the vascular and airway phenotypes?.

Myronenko O, Foris V, Crnkovic S, Olschewski A, Rocha S, Nicolls M Eur Respir Rev. 2023; 32(167).

PMID: 36631133 PMC: 9879331. DOI: 10.1183/16000617.0173-2022.


ROS and miRNA Dysregulation in Ovarian Cancer Development, Angiogenesis and Therapeutic Resistance.

Stieg D, Wang Y, Liu L, Jiang B Int J Mol Sci. 2022; 23(12).

PMID: 35743145 PMC: 9223852. DOI: 10.3390/ijms23126702.


Prospective Application of Ferroptosis in Hypoxic Cells for Tumor Radiotherapy.

Su J, Zhao Q, Zheng Z, Wang H, Bian C, Meng L Antioxidants (Basel). 2022; 11(5).

PMID: 35624785 PMC: 9137794. DOI: 10.3390/antiox11050921.


The regulation of cardiac intermediary metabolism by NADPH oxidases.

Nabeebaccus A, Reumiller C, Shen J, Zoccarato A, Santos C, Shah A Cardiovasc Res. 2022; 118(17):3305-3319.

PMID: 35325070 PMC: 9847558. DOI: 10.1093/cvr/cvac030.